Matt Herper has a nicely balanced piece in Forbes today. . . .

But first, do go read this -- it is related, and perfectly put!

At the end of the day, it would seem that the Pfizer/Lipitor non-result in CASHMERE really means. . . nothing to Vytorin/Zetia.

It comes out as a zero. Nada. Zip.

Do go read it, it is quite well-sourced and fairly-balanced.

~~~~~~~~~~~~

[I do wonder whether my own Fourth of July round-up was the germ of Matt Herper's idea for today's Forbes story. Yes, I do wonder -- someone from Forbes spent time reading the July 4, 2008 entry on July 5 and again, on July 6. Interesting.]